High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

Published:2020-01 Issue:1 Volume:15 Page:120-124
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Baldacci Simon,Figeac Martin,Antoine Martine,Descarpentries Clotilde,Kherrouche Zoulika,Jamme Philippe,Copin Marie-Christine,Tulasne David,Nanni Isabelle,Beau-Faller Michèle,Melaabi Samia,Levallet Guénaëlle,Quoix Elisabeth,Moro-Sibilot Denis,Friard Sylvie,Missy Pascale,Barlesi Fabrice,Cadranel Jacques,Cortot Alexis B.

Funder

Roche

Merck

Bristol-Myers Squibb

Boehringer Ingelheim

Chugai

AstraZeneca

Novartis

AbbVie

Amgen

Genentech

Ignyta

MedImmune

Sanofi-Aventis

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. The multiple paths towards MET receptor addiction in cancer;Duplaquet;Oncogene,2018

2. Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors;Frampton;Cancer Discov,2015

3. MET amplification and exon 14 splice site mutation define unique molecular subgroups of non–small cell lung carcinoma with poor prognosis;Tong;Clin Cancer Res,2016

4. Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: results from the European Thoracic Oncology Platform (ETOP) Lungscape project;Bubendorf;Lung Cancer,2017

5. c-MET Overexpression as a poor predictor of MET amplifications or exon 14 mutations in lung sarcomatoid carcinomas;Mignard;J Thorac Oncol,2018

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging;American Journal of Surgical Pathology;2024-07-08

2. Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer;Therapeutic Advances in Medical Oncology;2024-01

3. Genotype Versus Phenotype: Defining Predictive Biomarkers of Immunotherapy Response;Journal of Thoracic Oncology;2023-12

4. c-Met immunohistochemistry as reflex test at diagnosis for non-small cell lung cancer: a real-world experience from a monocentric case series;Journal of Clinical Pathology;2023-11-08

5. MET Exon 14 Skipping in NSCLC: A Systematic Literature Review of Epidemiology, Clinical Characteristics, and Outcomes;Clinical Lung Cancer;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3